Child health status, neurodevelopmental outcome, and parental satisfaction in a randomized, controlled trial of nitric oxide for persistent pulmonary hypertension of the newborn.

OBJECTIVE To describe health and neurodevelopmental outcomes and parental satisfaction with hospital care among surviving intervention and control enrollees in a randomized, controlled trial of nitric oxide for persistent pulmonary hypertension of the newborn (PPHN). METHODS All surviving enrollees 1 to 4 years of age were eligible for follow-up. Outcomes were assessed by telephone using a trained interviewer and standardized instruments. Domains assessed included parental report of specific conditions and hospital use, rating of general health, cognitive and motor development, behavior problems, temperament, and satisfaction with the hospital stay. Fisher's exact test and the Wilcoxon rank sum test assessed differences between intervention and control infants. RESULTS Interviews were completed on 60 of 83 survivors (72%). Eighteen families (22%) could not be located, 2 (2%) were non-English-speaking, and 3 (4%) declined participation. No postdischarge deaths were ascertained. Among those interviewed, race, income, and education of parents of intervention and controls were comparable, as were entry oxygenation index, extracorporeal oxygenation utilization, and days of hospitalization. No differences were found in pulmonary, neurologic, cognitive, behavioral, or neurosensory outcomes; hospital readmission rates; or parental ratings of child's health. The overall neurologic handicap rate was 15%. The rate of hearing deficit was 7%. The rate of significant behavioral problems was 26%. Levels of satisfaction expressed were high for each group. No differences in parental ratings were found between the 2 groups. CONCLUSIONS No adverse health or neurodevelopmental outcomes have been observed among infants treated with nitric oxide for PPHN. The parents of the critically ill infants enrolled in our clinical trial welcomed their child's inclusion and all expressed satisfaction with the care that their child received while at a tertiary care hospital. Enrollment in either arm of this randomized, controlled trial did not seem to affect parental satisfaction with the hospital care that their child received.

[1]  D. Wessel,et al.  Inhaled nitric oxide does not affect adenosine 5'-diphosphate-dependent platelet activation in infants with persistent pulmonary hypertension of the newborn. , 1998, Pediatrics.

[2]  A. Stark,et al.  Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn. , 1997, Pediatrics.

[3]  S. Abman,et al.  Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension. , 1997, The Journal of pediatrics.

[4]  Jesse D. Roberts,et al.  Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn , 1997 .

[5]  Cook,et al.  Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. , 1997, The New England journal of medicine.

[6]  H Klonoff-Cohen,et al.  Tracking strategies involving fourteen sources for locating a transient study sample: parents of sudden infant death syndrome infants and control infants. , 1996, American journal of epidemiology.

[7]  S. Ringer,et al.  Normal birth weight intensive care unit survivors: outcome assessment. , 1996, Pediatrics.

[8]  P. H. Papero,et al.  Neurodevelopmental status at age five years of neonates treated with extracorporeal membrane oxygenation. , 1995, The Journal of pediatrics.

[9]  F. Glascoe,et al.  The role of parents in the detection of developmental and behavioral problems. , 1995, Pediatrics.

[10]  H Harrison,et al.  The principles for family-centered neonatal care. , 1993, Pediatrics.

[11]  G. Peckham,et al.  Maternal rating of child health at school age: does the vulnerable child syndrome persist? , 1993, Pediatrics.

[12]  G. Peckham,et al.  When You're Only a Phone Call Away: A Comparison of the Information in Telephone and Face‐to-Face Interviews , 1993, Journal of developmental and behavioral pediatrics : JDBP.

[13]  L. S. James,et al.  Hearing and neurodevelopmental outcome in survivors of persistent pulmonary hypertension of the newborn. , 1992, Pediatrics.

[14]  J. Walton,et al.  Profile and stability of sensorineural hearing loss in persistent pulmonary hypertension of the newborn. , 1991, Journal of speech and hearing research.

[15]  A. Thompson,et al.  Ten years of extracorporeal membrane oxygenation: neurodevelopmental outcome. , 1991, Pediatrics.

[16]  R. Bartlett,et al.  Follow-up of infants treated with extracorporeal membrane oxygenation for newborn respiratory failure. , 1991, Pediatrics.

[17]  P. Glass,et al.  Morbidity for survivors of extracorporeal membrane oxygenation: neurodevelopmental outcome at 1 year of age. , 1989, Pediatrics.

[18]  J. Walton,et al.  Hearing loss in infants with persistent fetal circulation. , 1988, Pediatrics.

[19]  E. Bifano,et al.  Duration of hyperventilation and outcome in infants with persistent pulmonary hypertension. , 1988, Pediatrics.

[20]  J. Ware,et al.  Involving consumers in quality of care assessment. , 1988, Health affairs.

[21]  M. Scher,et al.  Seizures and infarction in neonates with persistent pulmonary hypertension. , 1986, Pediatric neurology.

[22]  R. Bartlett,et al.  One- to three-year outcome for 14 neonatal survivors of extracorporeal membrane oxygenation. , 1986, Pediatrics.

[23]  G. Herer,et al.  Progressive Sensorineural Hearing Loss in Survivors of Persistent Fetal Circulation , 1986, Ear and hearing.

[24]  J. Stevenson,et al.  Behaviour problems and language abilities at three years and behavioural deviance at eight years. , 1985, Journal of child psychology and psychiatry, and allied disciplines.

[25]  C. Leonard,et al.  Developmental follow-up of infants with persistent pulmonary hypertension of the newborn. , 1984, Clinics in perinatology.

[26]  B. Ferrara,et al.  Efficacy and neurologic outcome of profound hypocapneic alkalosis for the treatment of persistent pulmonary hypertension in infancy. , 1984, The Journal of pediatrics.

[27]  G. Peckham,et al.  Long‐term follow‐up of newborns with persistent pulmonary hypertension , 1984, Critical care medicine.

[28]  C. Leonard,et al.  Developmental follow-up of hyperventilated neonates: preliminary observations. , 1981, Pediatrics.

[29]  B. Starfield,et al.  Rehospitalization in the first year of life for high-risk survivors. , 1980, Pediatrics.

[30]  J. Ware,et al.  Measuring Components of Children's Health Status , 1979, Medical care.

[31]  J. Stevenson,et al.  Prevalence of behaviour problems in 3-year-old children: an epidemiological study in a London borough. , 1975, Journal of child psychology and psychiatry, and allied disciplines.

[32]  R. Bejar,et al.  Predictors of early childhood outcome in candidates for extracorporeal membrane oxygenation. , 1996, The Journal of pediatrics.

[33]  B. McNeil,et al.  Patient satisfaction as an indicator of quality care. , 1988, Inquiry : a journal of medical care organization, provision and financing.

[34]  J. Gaines,et al.  Persistent fetal circulation. Neurodevelopmental outcome. , 1985, American journal of diseases of children.

[35]  J E Ware,et al.  Defining and measuring patient satisfaction with medical care. , 1983, Evaluation and program planning.

[36]  N. Richman,et al.  A behavioural screening questionnaire for use with three-year-old children. Preliminary findings. , 1971, Journal of child psychology and psychiatry, and allied disciplines.